yf13h12 |
gastric cancer |
Commonly up-regulated genes in gastric cancer in comparison with normal gastric epithelia included CEACAM6, APOC1 and YF13H12. |
15132764 |
Human |
yf13h12 |
tumor |
Frequently overexpressed genes (tumor/normal ratio > 2) were COL1A1 (percentage of cases with overexpression, 78.3%), CDH17 (73.9%), APOC1 (67.4%), COL1A2 (58.7%), YF13H12 (52.2%), CEACAM6 (50.0%), APOE (50.0%), REGIV (47.8%), S100A11 (41.3%), and FUS (41 |
15059891 |
Human |
hsco |
hepatocellular carcinomas |
HSCO mRNA was overexpressed in 20 of 30 hepatocellular carcinomas analyzed. |
12398897 |
Human |
hsco |
hepatocarcinogenesis |
These results suggest that overexpression of HSCO suppresses p53-induced apoptosis by preventing nuclear localization of NF-kappa B during signaling and thus contributes to hepatocarcinogenesis. |
12398897 |
Human |
ethe1 |
hepatocellular carcinomas |
HSCO (hepatoma subtracted-cDNA library clone one, also called ETHE1) was originally identified by its frequent overexpression in hepatocellular carcinomas. |
17353187 |
Human |
ethe1 |
hepatoma |
HSCO (hepatoma subtracted-cDNA library clone one, also called ETHE1) was originally identified by its frequent overexpression in hepatocellular carcinomas. |
17353187 |
Human |
hsco |
hepatocellular carcinomas |
HSCO (hepatoma subtracted-cDNA library clone one, also called ETHE1) was originally identified by its frequent overexpression in hepatocellular carcinomas. |
17353187 |
Human |
hsco |
hepatoma |
HSCO (hepatoma subtracted-cDNA library clone one, also called ETHE1) was originally identified by its frequent overexpression in hepatocellular carcinomas. |
17353187 |
Human |
hsco |
hepatocellular carcinomas |
Treatment of hepatocellular carcinomas that retain wild-type p53 and overexpress HSCO with anti-HSCO agents might re-establish the p53 response and revert chemoresistance. |
17353187 |
Human |